Interleukin-1αβ gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain
暂无分享,去创建一个
Michael F. Jarvis | Michael W. Decker | Prisca Honore | Yoichiro Iwakura | M. Decker | T. Ghayur | Y. Iwakura | P. Honore | M. Jarvis | C. Faltynek | C. Zhong | Richard R. Harris | Carrie L. Wade | Chengmin Zhong | C. Wu | Tariq Ghayur | Connie Faltynek | James Sullivan | C. Wade | R. Harris | C. Wu | James Sullivan
[1] N. Rothwell,et al. Interleukin-1 Influences Ischemic Brain Damage in the Mouse Independently of the Interleukin-1 Type I Receptor , 2002, The Journal of Neuroscience.
[2] T. Yaksh,et al. Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.
[3] A. Panerai,et al. Interleukin‐1 and nociception in the rat , 1998, Journal of neuroscience research.
[4] S. Maier,et al. Characterization of cytokine-induced hyperalgesia , 1994, Brain Research.
[5] S. Raja,et al. A Mouse Model of Incisional Pain , 2003, Anesthesiology.
[6] M. Perretti,et al. Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice , 2005, Agents and Actions.
[7] R. Hen,et al. Commentary: The broken mouse: the role of development, plasticity and environment in the interpretation of phenotypic changes in knockout mice , 2000, Current Opinion in Neurobiology.
[8] Masatoshi Suzuki,et al. Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid Secretion , 1998, The Journal of experimental medicine.
[9] R. Dubner,et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia , 1987, Pain.
[10] L. Watkins,et al. Illness-induced hyperalgesia is mediated by a spinal NMDA-nitric oxide cascade , 1994, Brain Research.
[11] T. Brennan,et al. Intrathecal Metabotropic Glutamate Receptor Antagonists Do Not Decrease Mechanical Hyperalgesia in a Rat Model of Postoperative Pain , 1998, Anesthesia and analgesia.
[12] I. Goshen,et al. Impairment of interleukin-1 (IL-1) signaling reduces basal pain sensitivity in mice: genetic, pharmacological and developmental aspects , 2003, Pain.
[13] S. Maier,et al. Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin , 1993, Brain Research.
[14] S. Maier,et al. Spinal Glia and Proinflammatory Cytokines Mediate Mirror-Image Neuropathic Pain in Rats , 2003, The Journal of Neuroscience.
[15] N. Rothwell,et al. Role of IL-1α and IL-1β in Ischemic Brain Damage , 2001, The Journal of Neuroscience.
[16] K. Tan-No,et al. Induction of nociceptive responses by intrathecal injection of interleukin-1 in mice. , 1999, Life sciences.
[17] K. Török,et al. Measurement and drug induced modulation of interleukin-1 level during zymosan peritonitis in mice , 1995, Inflammation Research.
[18] Timothy J. Brennan,et al. Characterization of a rat model of incisional pain , 1996, Pain.
[19] S. Ferreira,et al. Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue , 1988, Nature.
[20] Y. Iwakura,et al. Primary Role of Interleukin-1α and Interleukin-1β in Lipopolysaccharide-Induced Hypoglycemia in Mice , 2002, Clinical and Vaccine Immunology.
[21] Gary J. Bennett,et al. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man , 1988, Pain.
[22] F. Cunha,et al. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[23] S. Maier,et al. Peri-sciatic proinflammatory cytokines, reactive oxygen species, and complement induce mirror-image neuropathic pain in rats , 2004, Pain.
[24] C. Dinarello,et al. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. , 1998, International reviews of immunology.
[25] C. Woolf,et al. Contribution of interleukin‐1β to the inflammation‐induced increase in nerve growth factor levels and inflammatory hyperalgesia , 1995, British journal of pharmacology.
[26] S. Nakae,et al. Development of Chronic Inflammatory Arthropathy Resembling Rheumatoid Arthritis in Interleukin 1 Receptor Antagonist–Deficient Mice , 2000, The Journal of experimental medicine.
[27] Jin Mo Chung,et al. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat , 1992, PAIN.
[28] S. Nakae,et al. Interleukin‐1β, but not interleukin‐1α, is required for T‐cell‐dependent antibody production , 2001 .
[29] C. Sommer,et al. Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy , 1999, Neuroscience Letters.
[30] A. Gomtsyan,et al. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat. , 2000, The Journal of pharmacology and experimental therapeutics.